National Institutes of Health (NIH)

New ways to tackle cancer-causing virus, eye disease win CTSI funding awards

A promising new way to fight human herpes viruses and a drug delivery device to better treat a major cause of blindness have won development funding from UCSF’s Clinical and Translational Science Institute (CTSI).

Child’s illness fuels lab team’s search for early-life epilepsy diagnostics

The lab of UCSF School of Pharmacy faculty member Nadav Ahituv, PhD, studies how abnormalities in DNA segments that control the activity of genes could lead to diseases. Recently, researchers there have begun applying that focus to seeking a genetic basis and diagnosis for an epilepsy of early...

Artificial kidney project led by Roy cited at White House panel

Speaking on a White House panel discussing President Obama's just-released Bioeconomy Blueprint, UCSF Vice Chancellor for Research Keith Yamamoto, PhD, cited the implantable bioartificial kidney project led by UCSF bioengineer Shuvo Roy, PhD, as a prime example of biomedical collaboration with...

Celebrating Burlingame’s contributions to mass spectrometry

From the start of his illustrious half-century career in mass spectrometry, Al Burlingame, PhD, has been part of a scientific sea change.

New NIH funding awarded to the Department of Bioengineering and Therapeutic Sciences in 2011

New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included a half-dozen on-going projects by BTS faculty:

UCSF School of Pharmacy’s 32nd year of top NIH funding includes many new projects

For the 32nd consecutive year, the UCSF School of Pharmacy received more research funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.

Reflection: 30 years of top NIH funding for UCSF School of Pharmacy

Table of contents

Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support
Research stalwarts draw funding for decades
New directions in translational research attract support
Expansion of the School’s...

Funding scarce for deep innovation in science

Today’s science lacks funding for truly deep innovation, says Ken Dill, PhD, UCSF School of Pharmacy faculty member and associate dean of research.

Full story

Science Cafe, Bring Back the Ivory Tower, Part 1 of 2

School #1 in NIH funding, 26th year

For the 26th consecutive year, the UCSF School of Pharmacy ranks first among US pharmacy schools in contract and grant funding from the National Institutes of Health (NIH), according to figures for fiscal year 2005.

UCSF School of Pharmacy tops NIH funding

The UCSF School of Pharmacy was the largest recipient of 2004 research funding from the National Institutes of Health (NIH) among pharmacy schools in the United States. The School's 2004 total NIH award funding was US$23.5 million.